Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04708392 · ClinicalTrials.gov registry record · NA

Stimulation Change Effects on Quantitative Sensory Testing in Neuromodulation Patients

A NA study, sponsored by Albany Medical College.

Completed
Registry status
NA
Development phase
16
Enrollment target

NCT04708392: Completed NA study, sponsored by Albany Medical College.

NCT04708392 is a NA study that has completed, run by Albany Medical College. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04708392, a NA study, has completed, sponsored by Albany Medical College.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

This study is designed to evaluate the effectiveness of two types of spinal cord stimulation programming types, in comparison to each other as well as patient baseline data.

Primary Outcome

Thermal stimulus testing - thermal stimulation system is used to record hot and cold sensation and pain thresholds.

Interventions

  • DEVICE Spinal Cord Stimulator

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2017-07-29
Est. Completion 2018-09-11
Phase NA
Albany Medical College

52 total trials

What the finished NCT04708392 record still lists

NCT04708392 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Spinal Cord Stimulator is the first listed.

NCT04708392 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04708392 about?

NCT04708392 is a clinical study titled "Stimulation Change Effects on Quantitative Sensory Testing in Neuromodulation Patients". This study is designed to evaluate the effectiveness of two types of spinal cord stimulation programming types, in comparison to each other as well as patient baseline data.

What is the current status of trial NCT04708392?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2017-07-29. Estimated completion is 2018-09-11.

What interventions are being tested in trial NCT04708392?

The interventions under investigation include: Spinal Cord Stimulator (DEVICE).

Who is sponsoring clinical trial NCT04708392?

This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04708392's enrollment target sits among peer trials

16 1871st of 2000 higher than 120 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04708392, the US trial registry maintained by the National Library of Medicine. NCT04708392 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.